Detecting Schizophrenia Early: Clinical Challenges and Future Directions
NeuroFrontiersDetecting Schizophrenia Early: Clinical Challenges and Future Directions
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
NeuroFrontiersOvercoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
NeuroFrontiersSupporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
NeuroFrontiersBeyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
Identifying and Managing Violence Risk in Schizophrenia Care
On the Frontlines of SchizophreniaIdentifying and Managing Violence Risk in Schizophrenia Care
Digital Danger: Understanding AI Psychosis in Schizophrenia
On the Frontlines of SchizophreniaDigital Danger: Understanding AI Psychosis in Schizophrenia
- advertisement
- 3 questions
- advertisement
New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
Medical Industry FeatureNew Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
Reassessing the Full Clinical Picture of ADHD
Medical Industry FeatureReassessing the Full Clinical Picture of ADHD
MMN in Practice: A Rare Motor Neuropathy Often Misdiagnosed
Medical Industry FeatureMMN in Practice: A Rare Motor Neuropathy Often Misdiagnosed
Aligning Efficacy With Patient Goals: The Role of SCIg in CIDP Maintenance
Medical Industry FeatureAligning Efficacy With Patient Goals: The Role of SCIg in CIDP Maintenance
From IVIg to SCIg: Rethinking Long-Term CIDP Therapy
Medical Industry FeatureFrom IVIg to SCIg: Rethinking Long-Term CIDP Therapy
- 01/16/2026
- 01/15/2026
- 01/14/2026
- 01/13/2026
- 01/12/2026
- 01/08/2026